Gilead Sciences to Present at the 29th Annual Goldman Sachs Global Healthcare Conference on Wednesday, June 11
June 04 2008 - 3:15PM
Business Wire
Gilead Sciences, Inc. (Nasdaq:GILD) today announced that its
corporate presentation will be webcast from the 29th Annual Goldman
Sachs Global Healthcare Conference in Dana Point, CA. John F.
Milligan, PhD, Gilead�s President and Chief Operating Officer, will
provide an overview of the company on Wednesday, June 11 at 2:40
p.m. Pacific Time (5:40 p.m. Eastern Time). To access the live
webcast via the internet log on to www.gilead.com. Please connect
to the company�s website at least 15 minutes prior to the start of
the presentation to ensure adequate time for any software download
that may be necessary to listen to the webcast. About Gilead Gilead
Sciences is a biopharmaceutical company that discovers, develops
and commercializes innovative therapeutics in areas of unmet
medical need. The company�s mission is to advance the care of
patients suffering from life-threatening diseases worldwide.
Headquartered in Foster City, California, Gilead has operations in
North America, Europe and Australia. For more information on Gilead
Sciences, please visit www.gilead.com or call the Gilead Public
Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Jul 2023 to Jul 2024